A possible explanation for this distinction comes from our previous observation that components of the microRNA biosynthetic pathway (i.e. the microprocessor complex (DGCR8 and Drosha)) are up-regulated in B-cell malignancies (including MM) but down-regulated in T-cell malignancies [29]. The gene discussed is DGCR8; the disease is cancer.